NOVONESIS (NOVOZYMES) B UNSP AD - stock earnings

NVZMY Quarterly earnings

DateEarningsRevenue
2023Q4 103.3 million USD 681.5 million USD
2023Q3 132.7 million USD 631.8 million USD
2023Q2 88.5 million USD 616.1 million USD
2023Q1 114.8 million USD 676.8 million USD
2022Q4 127.2 million USD 652.4 million USD
2022Q3 152.0 million USD 576.3 million USD
2022Q2 113.7 million USD 602.6 million USD
2022Q1 124.9 million USD 656.0 million USD
2021Q4 95.6 million USD 586.4 million USD
2021Q3 131.2 million USD 585.8 million USD
2021Q2 126.6 million USD 570.9 million USD
2021Q1 139.5 million USD 595.3 million USD
2020Q4 107.4 million USD 565.7 million USD
2020Q3 112.0 million USD 540.6 million USD
2020Q2 97.2 million USD 504.9 million USD
2020Q1 120.4 million USD 559.3 million USD
2019Q4 138.2 million USD 559.4 million USD
2019Q3 93.5 million USD 542.9 million USD
2019Q2 136.8 million USD 526.9 million USD
2019Q1 104.7 million USD 523.7 million USD
2018Q4 128.2 million USD 569.0 million USD
2018Q3 126.0 million USD 570.9 million USD
2018Q2 120.4 million USD 542.7 million USD
2018Q1 133.0 million USD 581.0 million USD
2017Q4 127.4 million USD 589.2 million USD
2017Q3 129.5 million USD 566.8 million USD
2017Q2 113.3 million USD 544.4 million USD
2017Q1 110.8 million USD 537.4 million USD
2016Q4 114.4 million USD 527.1 million USD
2016Q3 112.9 million USD 510.5 million USD
2016Q2 112.2 million USD 513.1 million USD
2016Q1 113.2 million USD 549.0 million USD
2015Q4 101.4 million USD 505.9 million USD
2015Q3 112.1 million USD 531.5 million USD
2015Q2 102.6 million USD 518.9 million USD
2015Q1 102.4 million USD 519.0 million USD
2014Q4 98.5 million USD 519.5 million USD
2014Q3 109.0 million USD 543.0 million USD
2014Q2 108.2 million USD 560.2 million USD
2014Q1 127.7 million USD 558.7 million USD
2013Q4 103.9 million USD 544.3 million USD
2013Q3 102.8 million USD 531.3 million USD
2013Q2 97.0 million USD 528.8 million USD
2013Q1 88.4 million USD 489.1 million USD
2012Q4 87.2 million USD 497.1 million USD
2012Q3 90.2 million USD 491.6 million USD
2012Q2 82.5 million USD 477.3 million USD
2012Q1 91.3 million USD 489.4 million USD
2011Q4 63.3 million USD 451.3 million USD
2011Q3 94.8 million USD 491.5 million USD
2011Q2 88.1 million USD 492.5 million USD
2011Q1 93.2 million USD 509.8 million USD
2010Q4 62.4 million USD 428.9 million USD
2010Q3 80.3 million USD 462.0 million USD
2010Q2 69.0 million USD 405.4 million USD
2010Q1 73.5 million USD 421.9 million USD
2009Q4 58.0 million USD 417.3 million USD
2009Q3 62.2 million USD 417.0 million USD
2009Q2 52.6 million USD 384.0 million USD
2009Q1 53.0 million USD 378.2 million USD

NVZMY Yearly earnings

DateEarningsRevenue
2023 447.7 million USD 2.6 billion USD
2022 529.5 million USD 2.5 billion USD
2021 481.2 million USD 2.3 billion USD
2020 463.7 million USD 2.3 billion USD
2019 472.9 million USD 2.2 billion USD
2018 494.3 million USD 2.2 billion USD
2017 500.3 million USD 2.3 billion USD
2016 432.9 million USD 2.0 billion USD
2015 413.7 million USD 2.1 billion USD
2014 412.6 million USD 2.0 billion USD
2013 407.3 million USD 2.2 billion USD
2012 356.3 million USD 2.0 billion USD
2011 318.6 million USD 1.8 billion USD
2010 288.0 million USD 1.7 billion USD
2009 229.9 million USD 1.6 billion USD
2008 198.5 million USD 1.5 billion USD
2007 204.1 million USD 1.5 billion USD
2006 161.2 million USD 1.2 billion USD
2005 136.7 million USD 996.9 million USD
2004 145.0 million USD 1.1 billion USD
2003 124.3 million USD 981.2 million USD
2002 91.3 million USD 796.5 million USD

NVZMY

Price: $59.52

52 week price:
38.75
61.86

5-year range yield:
0.53%
1.81%

Forward Dividend Yield: 0.48%

Payout Ratio: 18.26%

Payout Ratio Range:
7.61%
143.08%

Dividend Per Share: 0.29 USD

Earnings Per Share: 1.58 USD

P/E Ratio: 31.09

Exchange: PNK

Sector: Basic Materials

Industry: Specialty Chemicals

Volume: 22000

Ebitda: 811.9 million

Market Capitalization: 25.5 billion

Average Dividend Frequency: 1

Years Paying Dividends: 21

DGR3: 3.17%

DGR5: 2.89%

DGR10: 7.20%

Links: